Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/ADMA Biologics investigated for securities fraud after 29% stock drop over alleged channel stuffing.
ADMA
$8.86
+$0.18 +2.07%

ADMA Biologics investigated for securities fraud after 29% stock drop over alleged channel stuffing.

Market News
13 Apr 2026
GlobeNewsWire
View Source
Bearish
pluang ai news

ADMA Biologics is under investigation by law firm Bleichmar Fonti & Auld for potential securities fraud related to claims of channel stuffing. The allegations suggest the company inflated its 2025 revenue growth by inducing a distributor to stock excess product through rebates and extended payment terms, masking a real revenue decline of 3%. This report from Culper Research caused ADMA's stock to fall 29% over two days. Investors in ADMA Biologics are encouraged to seek legal advice as the investigation continues.

More News (ADMA)

Deadline nears for investors to join class action lawsuits against BTGO, VIA, Z, and ADMA for alleged securities fraud.

Deadline nears for investors to join class action lawsuits against BTGO, VIA, Z, and ADMA for alleged securities fraud.

Law Offices of Howard G. Smith reminds investors of approaching deadlines to file lead plaintiff motions in class action lawsuits against BitGo Holdings, Via Transportation, Zillow Group, and ADMA Biologics. These lawsuits allege the companies made f...

Market News
Bearish
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App